ARCHIVES

FDA Simplifies Reporting Of Adverse Events

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

October 25, 2013

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993

Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.

March 30, 2001